ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Pharvaris NV

Pharvaris NV (PHVS)

33.86
-0.09
(-0.27%)
終了 7月5日 5:00AM
33.75
-0.11
(-0.32%)
取引時間後: 8:59AM

Pharvaris NV (PHVS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
33.86
( -0.27% )
買値
31.78
売値
54.39
出来高
478,103
33.16 日の範囲 34.765
17.05 52 週間の範囲 35.905
時価総額
前日終値
33.95
始値
34.37
最終取引時間
財務取引量
US$ 16,227,194
VWAP
33.9408
平均取引量 (3 か月)
US$ 352,438
発行済株式数
69,879,726
配当利回り
PER
-10.94
1 株当たり利益 (EPS)
-2.72
歳入
-
純利益
-168.56M

Pharvaris NV について

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist ... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Zug, Switzerland
設立
2026
Pharvaris NV is listed in the Healthcare sector of the ナスダック市場 with ticker PHVS. The last closing price for Pharvaris NV was US$33.95. Over the last year, Pharvaris NV shares have traded in a share price range of US$ 17.05 to US$ 35.905.

Pharvaris NV currently has 69,879,726 shares in issue. The market capitalisation of Pharvaris NV is US$2.37 billion. Pharvaris NV has a price to earnings ratio (PE ratio) of -10.94.

PHVS 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.280.83382966051233.5835.90532.931562959334.23889201CS
43.8712.904301433829.9935.90529.5641331332.91660275CS
126.322.859216255427.5635.9052636114730.92145778CS
265.921.101573676727.9635.90523.6225828929.52456463CS
5216.4194.040114613217.4535.90517.0525503626.93325435CS
15618.41119.15857605215.4535.90511.5113791124.71403094CS
26016.898.475967174717.0635.9051.7718207917.15408901CS

PHVS - Frequently Asked Questions (FAQ)

What is the current Pharvaris NV share price?
The current share price of Pharvaris NV is US$ 33.86
How many Pharvaris NV shares are in issue?
Pharvaris NV has 69,879,726 shares in issue
What is the market cap of Pharvaris NV?
The market capitalisation of Pharvaris NV is USD 2.37B
What is the 1 year trading range for Pharvaris NV share price?
Pharvaris NV has traded in the range of US$ 17.05 to US$ 35.905 during the past year
What is the PE ratio of Pharvaris NV?
The price to earnings ratio of Pharvaris NV is -10.94
What is the registered address of Pharvaris NV?
The registered address for Pharvaris NV is Grafenauweg 8, Zug, Zug, 6300
What is the Pharvaris NV website address?
The website address for Pharvaris NV is pharvaris.com
Which industry sector does Pharvaris NV operate in?
Pharvaris NV operates in the Biotechnology & Life Sciences sector

PHVS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

PHVS Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock